Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline ...

Retrieved on: 2021-04-12 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline .... View article details on hiswai:

Excerpt

ENGLEWOOD, CO / ACCESSWIRE / April 12, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on ...

Article found on: www.biospace.com